(Q40319128)

English

Disease-specific expression of VEGF and its receptors in AML cells: possible autocrine pathway of VEGF/type1 receptor of VEGF in t(15;17) AML and VEGF/type2 receptor of VEGF in t(8;21) AML.

scientific article published on January 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Disease-specific expression of VEGF and its receptors in AML cells: possible autocrine pathway of VEGF/type1 receptor of VEGF in t(15;17) AML and VEGF/type2 receptor of VEGF in t(8;21) AML. (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

author name string

A Hiramatsu

1

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

H Miwa

2

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

M Shikami

3

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

T Ikai

4

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

E Tajima

5

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

H Yamamoto

6

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

N Imai

7

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

A Hattori

8

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

T Kyo

9

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

M Watarai

10

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

K Miura

11

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

A Satoh

12

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

M Itoh

13

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

A Imamura

14

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

H Mihara

15

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Y Katoh

16

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

M Nitta

17

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

publication date

1 January 2006

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Leukemia & Lymphoma

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

47

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

89-95

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene

1 reference

https://api.crossref.org/works/10.1080%2F10428190500270386

21 January 2018

VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism

1 reference

https://api.crossref.org/works/10.1080%2F10428190500270386

21 January 2018

Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration

1 reference

https://api.crossref.org/works/10.1080%2F10428190500270386

21 January 2018

Vascular endothelial cell growth factor is an autocrine promoter of abnormal localized immature myeloid precursors and leukemia progenitor formation in myelodysplastic syndromes.

1 reference

https://api.crossref.org/works/10.1080%2F10428190500270386

21 January 2018

Internal and external autocrine VEGF/KDR loops regulate survival of subsets of acute leukemia through distinct signaling pathways

1 reference

https://api.crossref.org/works/10.1080%2F10428190500270386

21 January 2018

Vascular endothelial growth factor receptor-1 and receptor-2 initiate a phosphatidylinositide 3-kinase-dependent clonogenic response in acute myeloid leukemia cells

1 reference

https://api.crossref.org/works/10.1080%2F10428190500270386

21 January 2018

Inhibition of both paracrine and autocrine VEGF/ VEGFR-2 signaling pathways is essential to induce long-term remission of xenotransplanted human leukemias

1 reference

https://api.crossref.org/works/10.1080%2F10428190500270386

21 January 2018

VEGF and myeloid leukemias

1 reference

https://api.crossref.org/works/10.1080%2F10428190500270386

21 January 2018

A phase 1 study of SU11248 in the treatment of patients with refractory or resistant acute myeloid leukemia (AML) or not amenable to conventional therapy for the disease

1 reference

https://api.crossref.org/works/10.1080%2F10428190500270386

21 January 2018

Targeting vascular endothelial growth factor for relapsed and refractory adult acute myelogenous leukemias: therapy with sequential 1-beta-d-arabinofuranosylcytosine, mitoxantrone, and bevacizumab

1 reference

https://api.crossref.org/works/10.1080%2F10428190500270386

21 January 2018

Molecular structure of the human cytoplasmic beta-actin gene: interspecies homology of sequences in the introns

1 reference

https://api.crossref.org/works/10.1080%2F10428190500270386

21 January 2018

Efficacy and safety of imatinib in adult patients with c-kit-positive acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1080%2F10428190500270386

21 January 2018

A phase 2 clinical study of SU5416 in patients with refractory acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1080%2F10428190500270386

21 January 2018

Identifiers

10.1080/10428190500270386

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40319128&oldid=1489699851"